# Cyclophosphamide

NDC: 0338-9779
Generic name: cyclophosphamide injection, solution
Labeler / Manufacturer: Baxter Healthcare Company
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20240801

FDA application: NDA217651

## Active ingredients

- CYCLOPHOSPHAMIDE: 200 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0338-9779"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0338-9779
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=34dbffee-80e0-49c3-90e8-95713a0b7fbe